Influence of donor HO-1 polymorphism genotype on late kidney transplantation outcome (2007)
- Authors:
- Autor USP: CÂMARA, NIELS OLSEN SARAIVA - ICB
- Unidade: ICB
- Assunto: IMUNOLOGIA
- Language: Inglês
- Imprenta:
- Publisher: Sociedade Brasileira de Nefrologia
- Publisher place: Rio de Janeiro
- Date published: 2007
- Source:
- Título do periódico: Abstracts
- Conference titles: World Congress of Nephrology
-
ABNT
OZAKI, K. S. et al. Influence of donor HO-1 polymorphism genotype on late kidney transplantation outcome. 2007, Anais.. Rio de Janeiro: Sociedade Brasileira de Nefrologia, 2007. . Acesso em: 21 maio 2024. -
APA
Ozaki, K. S., Marques, G. M., Nogueira, E., Cenedeze, A. A., Feitoza, R. Q., Mazzalli, M., et al. (2007). Influence of donor HO-1 polymorphism genotype on late kidney transplantation outcome. In Abstracts. Rio de Janeiro: Sociedade Brasileira de Nefrologia. -
NLM
Ozaki KS, Marques GM, Nogueira E, Cenedeze AA, Feitoza RQ, Mazzalli M, Soares MP, Bach FH, Câmara NOS, Pacheco-Silva A, Câmara NOS. Influence of donor HO-1 polymorphism genotype on late kidney transplantation outcome. Abstracts. 2007 ;[citado 2024 maio 21 ] -
Vancouver
Ozaki KS, Marques GM, Nogueira E, Cenedeze AA, Feitoza RQ, Mazzalli M, Soares MP, Bach FH, Câmara NOS, Pacheco-Silva A, Câmara NOS. Influence of donor HO-1 polymorphism genotype on late kidney transplantation outcome. Abstracts. 2007 ;[citado 2024 maio 21 ] - Pioglitazone limits cyclosporine nephrotoxicity in rats
- The role of toll-like receptor 4 in cisplatin-induced renal injury
- A role for HO-1 in the renal function impairment inrapamucin-treated animals submitted to ischemic and reperfusion injury (IRI)
- Renal transplantation outcomes: a comparative analysis between elderly and younger recipients
- High expression of Tim-3 mRNA in urinary cells from kidney transplant recipients with acute rejection
- Detection of Vbeta11 positive cells inside renal allograft during acute rejection
- PPARg agonists on renal ischemia/reperfusion injury
- Role of PPARy-activation in established chronic cyclosporine nephrotoxicity
- Mesenchymal stem cell therapy in remnant kidney fibrotic model does not improve long term renal outcome
- Imunobiologia do transplante
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
